Stockscreener 앱 받기
117.56
0.47%
-0.32
전일 마감가:
$117.88
열려 있는:
$118.25
하루 거래량:
127.41K
Relative Volume:
0.09
시가총액:
$13.10B
수익:
$2.90B
순이익/손실:
$239.11M
주가수익비율:
55.72
EPS:
2.1097
순현금흐름:
$492.62M
1주 성능:
+2.70%
1개월 성능:
+5.59%
6개월 성능:
+22.17%
1년 성능:
+29.03%
1일 변동 폭
$115.67
$118.34
1주일 범위
$112.68
$118.34
52주 변동 폭
$81.22
$118.34
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, IDXX, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
117.37 | 13.15B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
601.88 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.66 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
313.57 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
568.24 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.86 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Goldman | Neutral |
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Understanding the Setup: (RVTY) and Scalable Risk - Stock Traders Daily
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q) - marketscreener.com
Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit - stocktitan.net
Revvity (RVTY) Q2 2026 Earnings Call Transcript - AOL.com
Revvity to Present at Upcoming Investor Conferences - Business Wire
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Revvity Launches Superflex Prenatal Screening System - marketscreener.com
Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation With A 5.59% Upside - directorstalkinterviews.com
Bank of America Corp DE Increases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity Q2 Earnings Call Highlights - TradingView
Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative - webull.com
Revvity (NYSE:RVTY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (0KHE) Q3 2022 Earnings ReportResults, Call & Slides - tipranks.com
REVVITY, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $100 - webull.com
Revvity (NYSE:RVTY) Rating Increased to Hold at Zacks Research - MarketBeat
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY? - Yahoo Finance
Why Revvity (RVTY) Stock Is Up Today - The Globe and Mail
Stifel raises Revvity stock price target to $110 on earnings beat - Investing.com
REVVITY, INC. : JP MORGAN RAISES TARGET PRICE TO $110 FROM $90 - Moomoo
Revvity posts solid Q2 2026 earnings growth - The Globe and Mail
Amundi Sells 32,858 Shares of Revvity Inc. $RVTY - MarketBeat
Evercore ISI Adjusts Price Target on Revvity to $126 From $125, Maintains Outperform Rating - Yahoo Finance
Revvity, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Revvity Inc (RVTY) Shares Fall 3.3% -- What GF Score of 75 Tells Investors - GuruFocus
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
No-Moat Revvity Sees Solid First-Half Performance With Momentum Likely to Continue - Morningstar
Revvity, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:RVTY) 2026-08-04 - Seeking Alpha
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up - Yahoo Finance
Earnings call transcript: Revvity beats Q2 2026 estimates, but shares fall premarket - Investing.com
Revvity Inc (RVTY) (Q2 2026) Earnings Call Highlights: Strong Di - GuruFocus
Revvity, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Revvity (NYSE:RVTY) Issues FY 2026 Earnings Guidance - MarketBeat
Revvity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 05, 2026 - marketscreener.com
Revvity raises annual profit, revenue forecasts on strong diagnostics demand - Yahoo! Finance Canada
Revvity Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Revvity Inc (RVTY) Undervalued? Q2 Earnings Report Shows GAAP - GuruFocus
Transcript: Revvity Q2 2026 Earnings Conference Call - Benzinga
Revvity Tops Second-Quarter Estimates and Lifts Full-Year Outlook - Yahoo Finance
Q2 2026 Revvity Inc Earnings Call Transcript - GuruFocus
Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Revvity beats estimates, raises guidance as stock jumps - Investing.com
Earnings Flash (RVTY) Revvity, Inc. Reports Q2 Revenue $729.7M, vs. FactSet Est of $703.0M - marketscreener.com
Earnings Flash (RVTY) Revvity, Inc. Posts Q2 Adjusted EPS $1.41 per Share, vs. FactSet Est of $1.21 - marketscreener.com
Revvity Q2 revenue rises to $730 million as company raises 2026 guidance - Quiver Quantitative
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.41%
자본화:
|
볼륨(24시간):